GlassScriptPhysician profile
Lissette E Machin
NPI 1033144357
$5,030.51
in general payments reported to CMS, 2019-2025
35 companies · $557 in 2025
The $557 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,019 · 2020: $347 · 2021: $1,133 · 2022: $1,164 · 2023: $482 · 2024: $328 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.46 |
| Education | $113.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,247.79 | 2019-2025 | Wegovy |
| Abbvie INC. | $1,094.46 | 2019-2023 | |
| Astellas Pharma US INC | $470.62 | 2021-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $332.34 | 2019-2023 | Injectafer |
| Aspira Women'S Health INC | $249.02 | 2021-2022 | |
| Organon LLC | $146.66 | 2021-2025 | Nexplanon |
| Intuitive Surgical, INC. | $144.23 | 2019 | |
| Pfizer INC. | $140.20 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $122.56 | 2019 | |
| Axonics, INC. | $105.53 | 2021 | |
| Mayne Pharma Commercial LLC | $100.59 | 2021-2025 | |
| Therapeuticsmd, INC. | $82.63 | 2019-2022 | |
| Exeltis, USA INC. | $80.71 | 2022-2025 | Slynd |
| Coopersurgical, INC. | $71.10 | 2019-2023 | Summit Doppler |
| Lilly USA, LLC | $68.45 | 2023-2025 | Zepbound |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $65.47 | 2023-2025 | Gemtesa, Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $62.30 | 2019-2023 | |
| Evofem Biosciences, INC. | $45.01 | 2020-2024 | |
| Urovant Sciences INC | $42.16 | 2022 | |
| Hologic Sales and Service, LLC | $41.28 | 2019-2021 | |
| Shield Therapeutics INC | $37.92 | 2024 | |
| Amag Pharmaceuticals, INC. | $31.98 | 2019 | |
| Agile Therapeutics, INC. | $31.77 | 2021 | |
| Lupin INC. | $29.14 | 2020-2021 | |
| Duchesnay USA Incorporated | $26.23 | 2019 | |
| Smith+Nephew, INC. | $24.56 | 2019-2020 | |
| Coloplast Corp | $16.06 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.75 | 2021 | |
| Avion Pharmaceuticals | $15.75 | 2022 | |
| Acella Pharmaceuticals, LLC | $15.64 | 2024 | NP Thyroid 60 |
| Amgen INC. | $15.15 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.94 | 2021 | |
| Eisai INC. | $14.60 | 2019 | |
| Currax Pharmaceuticals LLC | $14.56 | 2022 | |
| Millicent US INC | $13.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lissette Machin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.